News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
113,163 Results
Type
Article (7652)
Company Profile (23)
Press Release (105483)
Multimedia
Podcasts (9)
Webinars (4)
Section
Business (28248)
Career Advice (603)
Deals (4611)
Drug Delivery (16)
Drug Development (13814)
Employer Resources (25)
FDA (3328)
Job Trends (2579)
News (50457)
Policy (4603)
Tag
2027 Pharm Country Standard (1)
Academia (694)
Academic (1)
Accelerated approval (8)
Adcomms (2)
Allergies (28)
Alliances (9784)
ALS (57)
Alzheimer's disease (306)
Antibody-drug conjugate (ADC) (51)
Approvals (3382)
Artificial intelligence (200)
Autoimmune disease (17)
Automation (15)
Bankruptcy (37)
Best Places to Work (2143)
BIOSECURE Act (3)
Biosimilars (13)
Biotechnology (16)
Bladder cancer (16)
Brain cancer (15)
Breast cancer (133)
Cancer (978)
Cardiovascular disease (85)
Career advice (473)
Career pathing (9)
CAR-T (47)
CDC (5)
Cell therapy (145)
Cervical cancer (8)
Clinical research (12370)
Collaboration (420)
Compensation (51)
Complete response letters (7)
COVID-19 (716)
CRISPR (28)
C-suite (122)
Cystic fibrosis (24)
Data (1320)
Decentralized trials (1)
Denatured (6)
Depression (29)
Diabetes (103)
Diagnostics (1686)
Digital health (14)
Diversity, equity & inclusion (5)
Drug discovery (91)
Drug pricing (26)
Duchenne muscular dystrophy (35)
Earnings (8894)
Editorial (10)
Employer branding (4)
Employer resources (23)
Events (13189)
Executive appointments (165)
FDA (4252)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (4)
Funding (341)
Gene editing (51)
Generative AI (22)
Gene therapy (172)
GLP-1 (178)
Government (892)
Guidances (73)
Healthcare (2950)
HIV (8)
Huntington's disease (10)
IgA nephropathy (7)
Immunology and inflammation (31)
Immuno-oncology (9)
Indications (22)
Infectious disease (792)
Inflammatory bowel disease (15)
Inflation Reduction Act (3)
Influenza (40)
Intellectual property (48)
Interviews (82)
IPO (1729)
IRA (7)
Job creations (498)
Job search strategy (394)
JPM (10)
Kidney cancer (3)
Labor market (14)
Layoffs (61)
Leadership (13)
Legal (472)
Liver cancer (27)
Longevity (2)
Lung cancer (125)
Lymphoma (131)
Machine learning (13)
Management (10)
Manufacturing (207)
MASH (51)
Medical device (2369)
Medtech (2379)
Mergers & acquisitions (3082)
Metabolic disorders (253)
Multiple sclerosis (21)
NASH (2)
Neurodegenerative disease (69)
Neuropsychiatric disorders (13)
Neuroscience (613)
Neurotech (1)
NextGen: Class of 2026 (1148)
Non-profit (745)
Now hiring (1)
Obesity (90)
Opinion (65)
Ovarian cancer (30)
Pain (63)
Pancreatic cancer (54)
Parkinson's disease (80)
Partnered (9)
Patents (90)
Patient recruitment (110)
Peanut (12)
People (8366)
Pharmaceutical (2)
Phase 1 (3484)
Phase 2 (5684)
Phase 3 (4530)
Pipeline (1154)
Policy (45)
Postmarket research (300)
Preclinical (1201)
Press Release (42)
Prostate cancer (51)
Psychedelics (6)
Radiopharmaceuticals (52)
Rare diseases (195)
Real estate (1101)
Recruiting (14)
Regulatory (4289)
Reports (14)
Research institute (694)
Resumes & cover letters (149)
Rett syndrome (16)
RNA editing (2)
RSV (9)
Schizophrenia (42)
Series A (52)
Series B (26)
Service/supplier (3)
Sickle cell disease (13)
Special edition (3)
Spinal muscular atrophy (50)
Sponsored (14)
Startups (666)
Supply chain (23)
Tariffs (9)
The Weekly (2)
Vaccines (206)
Venture capital (17)
Weight loss (55)
Women's health (25)
Worklife (1)
Date
Last 7 days (106)
Last 30 days (413)
Last 365 days (5834)
2026 (546)
2025 (5975)
2024 (6311)
2023 (7150)
2022 (10540)
2021 (10531)
2020 (10143)
2019 (7954)
2018 (6338)
2017 (5924)
2016 (5374)
2015 (5951)
2014 (4015)
2013 (3476)
2012 (3538)
2011 (3795)
2010 (3193)
Location
Africa (176)
Alabama (11)
Arizona (32)
Arkansas (4)
Asia (7233)
Australia (1283)
California (2029)
Canada (570)
China (204)
Colorado (87)
Connecticut (118)
Delaware (80)
Europe (16328)
Florida (367)
Georgia (138)
Hawaii (1)
Idaho (4)
Illinois (139)
India (12)
Indiana (68)
Iowa (4)
Japan (92)
Kansas (40)
Kentucky (4)
Louisiana (4)
Maine (6)
Maryland (242)
Massachusetts (1382)
Michigan (39)
Minnesota (114)
Mississippi (3)
Missouri (27)
Montana (7)
Nebraska (6)
Nevada (48)
New Hampshire (18)
New Jersey (657)
New Mexico (8)
New York (643)
North Carolina (320)
North Dakota (5)
Northern California (1044)
Ohio (54)
Oklahoma (13)
Oregon (8)
Pennsylvania (360)
Puerto Rico (9)
Rhode Island (11)
South America (242)
South Carolina (8)
South Dakota (1)
Southern California (750)
Tennessee (51)
Texas (378)
United States (7467)
Utah (30)
Vermont (1)
Virginia (47)
Washington D.C. (10)
Washington State (117)
West Virginia (2)
Wisconsin (16)
113,163 Results for "fast biomedical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
$207B Market Shift: The Race for Fast Track Approval in Oncology
February 5, 2026
·
10 min read
Press Releases
QTX-2101 Awarded FDA Fast Track Designation for the Treatment of Acute Promyelocytic Leukemia
January 30, 2026
·
2 min read
Press Releases
FDA grants Zenith’s ZEN-3694 Fast Track Status
Zenith Epigenetics Announces Grant of U.S. Food and Drug Administration Fast Track Designation for ZEN-3694 in NUT Carcinoma
July 14, 2025
·
5 min read
Press Releases
INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™
January 8, 2026
·
4 min read
Press Releases
OPDIVO® Plus YERVOY® Reimbursed Under Ontario’s FAST Program as First-Line Treatment for Advanced Liver Cancer
February 3, 2026
·
4 min read
Business
JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff
Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted a 2028 launch. CEO Albert Bourla explained the pharma’s strategy at J.P. Morgan on Monday.
January 13, 2026
·
3 min read
·
Nick Paul Taylor
Press Releases
SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247
January 21, 2026
·
6 min read
Press Releases
AstraZeneca’s Tagrisso® and Calquence® Among First Oncology Treatments Granted Accelerated Access Through Ontario’s FAST Program
January 26, 2026
·
6 min read
Press Releases
Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer
February 5, 2026
·
6 min read
Press Releases
MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day
February 2, 2026
·
23 min read
1 of 11,317
Next
